It is reported that among patients with acute coronary syndrome, the odds of developing bleeding complications in DM patients receiving insulin treatment is 2.3 times that of nDM patients (Cavallari et al., 2021); however, no statistical difference was observed between DM patients not receiving insulin treatment and nDM patients (Cavallari et al., 2021). This evidence concerns the gene INS and diabetes mellitus.